Cargando…
P874: LONG-TERM REMISSION AND SURVIVAL IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA AFTER TREATMENT OF LCAR-B38M CAR-T – AT LEAST 5-YEAR FOLLOW-UP IN LEGEND-2
| Autores principales: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431000/ http://dx.doi.org/10.1097/01.HS9.0000970400.98418.89 |
| _version_ | 1785091094623551488 |
|---|---|
| author | MI, Jian‑qing Zhao, Wan‑hong Chen, Li‑juan Fu, Weijun Wang, Bai‑yan Xu, Jie Liu, Jie Jin, Shi‑wei Zhu, Han Du, Juan Jiang, Hua Sun, Huabin Jia, Yehui Fan, Xiao‑hu LI, Jian‑yong Hou, Jian Chen, Zhu Zhang, Wang‑gang He, Ai‑li Chen, Sai‑juan |
| author_facet | MI, Jian‑qing Zhao, Wan‑hong Chen, Li‑juan Fu, Weijun Wang, Bai‑yan Xu, Jie Liu, Jie Jin, Shi‑wei Zhu, Han Du, Juan Jiang, Hua Sun, Huabin Jia, Yehui Fan, Xiao‑hu LI, Jian‑yong Hou, Jian Chen, Zhu Zhang, Wang‑gang He, Ai‑li Chen, Sai‑juan |
| author_sort | MI, Jian‑qing |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10431000 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104310002023-08-17 P874: LONG-TERM REMISSION AND SURVIVAL IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA AFTER TREATMENT OF LCAR-B38M CAR-T – AT LEAST 5-YEAR FOLLOW-UP IN LEGEND-2 MI, Jian‑qing Zhao, Wan‑hong Chen, Li‑juan Fu, Weijun Wang, Bai‑yan Xu, Jie Liu, Jie Jin, Shi‑wei Zhu, Han Du, Juan Jiang, Hua Sun, Huabin Jia, Yehui Fan, Xiao‑hu LI, Jian‑yong Hou, Jian Chen, Zhu Zhang, Wang‑gang He, Ai‑li Chen, Sai‑juan Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431000/ http://dx.doi.org/10.1097/01.HS9.0000970400.98418.89 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters MI, Jian‑qing Zhao, Wan‑hong Chen, Li‑juan Fu, Weijun Wang, Bai‑yan Xu, Jie Liu, Jie Jin, Shi‑wei Zhu, Han Du, Juan Jiang, Hua Sun, Huabin Jia, Yehui Fan, Xiao‑hu LI, Jian‑yong Hou, Jian Chen, Zhu Zhang, Wang‑gang He, Ai‑li Chen, Sai‑juan P874: LONG-TERM REMISSION AND SURVIVAL IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA AFTER TREATMENT OF LCAR-B38M CAR-T – AT LEAST 5-YEAR FOLLOW-UP IN LEGEND-2 |
| title | P874: LONG-TERM REMISSION AND SURVIVAL IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA AFTER TREATMENT OF LCAR-B38M CAR-T – AT LEAST 5-YEAR FOLLOW-UP IN LEGEND-2 |
| title_full | P874: LONG-TERM REMISSION AND SURVIVAL IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA AFTER TREATMENT OF LCAR-B38M CAR-T – AT LEAST 5-YEAR FOLLOW-UP IN LEGEND-2 |
| title_fullStr | P874: LONG-TERM REMISSION AND SURVIVAL IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA AFTER TREATMENT OF LCAR-B38M CAR-T – AT LEAST 5-YEAR FOLLOW-UP IN LEGEND-2 |
| title_full_unstemmed | P874: LONG-TERM REMISSION AND SURVIVAL IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA AFTER TREATMENT OF LCAR-B38M CAR-T – AT LEAST 5-YEAR FOLLOW-UP IN LEGEND-2 |
| title_short | P874: LONG-TERM REMISSION AND SURVIVAL IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA AFTER TREATMENT OF LCAR-B38M CAR-T – AT LEAST 5-YEAR FOLLOW-UP IN LEGEND-2 |
| title_sort | p874: long-term remission and survival in patients with relapsed or refractory multiple myeloma after treatment of lcar-b38m car-t – at least 5-year follow-up in legend-2 |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431000/ http://dx.doi.org/10.1097/01.HS9.0000970400.98418.89 |
| work_keys_str_mv | AT mijianqing p874longtermremissionandsurvivalinpatientswithrelapsedorrefractorymultiplemyelomaaftertreatmentoflcarb38mcartatleast5yearfollowupinlegend2 AT zhaowanhong p874longtermremissionandsurvivalinpatientswithrelapsedorrefractorymultiplemyelomaaftertreatmentoflcarb38mcartatleast5yearfollowupinlegend2 AT chenlijuan p874longtermremissionandsurvivalinpatientswithrelapsedorrefractorymultiplemyelomaaftertreatmentoflcarb38mcartatleast5yearfollowupinlegend2 AT fuweijun p874longtermremissionandsurvivalinpatientswithrelapsedorrefractorymultiplemyelomaaftertreatmentoflcarb38mcartatleast5yearfollowupinlegend2 AT wangbaiyan p874longtermremissionandsurvivalinpatientswithrelapsedorrefractorymultiplemyelomaaftertreatmentoflcarb38mcartatleast5yearfollowupinlegend2 AT xujie p874longtermremissionandsurvivalinpatientswithrelapsedorrefractorymultiplemyelomaaftertreatmentoflcarb38mcartatleast5yearfollowupinlegend2 AT liujie p874longtermremissionandsurvivalinpatientswithrelapsedorrefractorymultiplemyelomaaftertreatmentoflcarb38mcartatleast5yearfollowupinlegend2 AT jinshiwei p874longtermremissionandsurvivalinpatientswithrelapsedorrefractorymultiplemyelomaaftertreatmentoflcarb38mcartatleast5yearfollowupinlegend2 AT zhuhan p874longtermremissionandsurvivalinpatientswithrelapsedorrefractorymultiplemyelomaaftertreatmentoflcarb38mcartatleast5yearfollowupinlegend2 AT dujuan p874longtermremissionandsurvivalinpatientswithrelapsedorrefractorymultiplemyelomaaftertreatmentoflcarb38mcartatleast5yearfollowupinlegend2 AT jianghua p874longtermremissionandsurvivalinpatientswithrelapsedorrefractorymultiplemyelomaaftertreatmentoflcarb38mcartatleast5yearfollowupinlegend2 AT sunhuabin p874longtermremissionandsurvivalinpatientswithrelapsedorrefractorymultiplemyelomaaftertreatmentoflcarb38mcartatleast5yearfollowupinlegend2 AT jiayehui p874longtermremissionandsurvivalinpatientswithrelapsedorrefractorymultiplemyelomaaftertreatmentoflcarb38mcartatleast5yearfollowupinlegend2 AT fanxiaohu p874longtermremissionandsurvivalinpatientswithrelapsedorrefractorymultiplemyelomaaftertreatmentoflcarb38mcartatleast5yearfollowupinlegend2 AT lijianyong p874longtermremissionandsurvivalinpatientswithrelapsedorrefractorymultiplemyelomaaftertreatmentoflcarb38mcartatleast5yearfollowupinlegend2 AT houjian p874longtermremissionandsurvivalinpatientswithrelapsedorrefractorymultiplemyelomaaftertreatmentoflcarb38mcartatleast5yearfollowupinlegend2 AT chenzhu p874longtermremissionandsurvivalinpatientswithrelapsedorrefractorymultiplemyelomaaftertreatmentoflcarb38mcartatleast5yearfollowupinlegend2 AT zhangwanggang p874longtermremissionandsurvivalinpatientswithrelapsedorrefractorymultiplemyelomaaftertreatmentoflcarb38mcartatleast5yearfollowupinlegend2 AT heaili p874longtermremissionandsurvivalinpatientswithrelapsedorrefractorymultiplemyelomaaftertreatmentoflcarb38mcartatleast5yearfollowupinlegend2 AT chensaijuan p874longtermremissionandsurvivalinpatientswithrelapsedorrefractorymultiplemyelomaaftertreatmentoflcarb38mcartatleast5yearfollowupinlegend2 |